BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1300 related articles for article (PubMed ID: 35173711)

  • 1. Multifocal Cerebral Microinfarcts Modulate Early Alzheimer's Disease Pathology in a Sex-Dependent Manner.
    Lecordier S; Pons V; Rivest S; ElAli A
    Front Immunol; 2021; 12():813536. PubMed ID: 35173711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzo(a)pyrene exposure induced neuronal loss, plaque deposition, and cognitive decline in APP/PS1 mice.
    Liu D; Zhao Y; Qi Y; Gao Y; Tu D; Wang Y; Gao HM; Zhou H
    J Neuroinflammation; 2020 Aug; 17(1):258. PubMed ID: 32867800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
    Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
    Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p110δ PI3-Kinase Inhibition Perturbs APP and TNFα Trafficking, Reduces Plaque Burden, Dampens Neuroinflammation, and Prevents Cognitive Decline in an Alzheimer's Disease Mouse Model.
    Martínez-Mármol R; Mohannak N; Qian L; Wang T; Gormal RS; Ruitenberg MJ; Vanhaesebroeck B; Coulson EJ; Meunier FA
    J Neurosci; 2019 Oct; 39(40):7976-7991. PubMed ID: 31363064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
    Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
    CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterozygous CX3CR1 Deficiency in Microglia Restores Neuronal β-Amyloid Clearance Pathways and Slows Progression of Alzheimer's Like-Disease in PS1-APP Mice.
    Hickman SE; Allison EK; Coleman U; Kingery-Gallagher ND; El Khoury J
    Front Immunol; 2019; 10():2780. PubMed ID: 31849963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Beneficial Effects of Combining Anti-Aβ Antibody NP106 and Curcumin Analog TML-6 on the Treatment of Alzheimer's Disease in APP/PS1 Mice.
    Su IJ; Hsu CY; Shen S; Chao PK; Hsu JT; Hsueh JT; Liang JJ; Hsu YT; Shie FS
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice.
    Chen Y; Zhao S; Fan Z; Li Z; Zhu Y; Shen T; Li K; Yan Y; Tian J; Liu Z; Zhang B
    Alzheimers Res Ther; 2021 Feb; 13(1):40. PubMed ID: 33563332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial Endothelial Nitric Oxide Synthase Deficiency Exacerbates Cognitive Deficit and Amyloid Pathology in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease.
    Ahmed S; Jing Y; Mockett BG; Zhang H; Abraham WC; Liu P
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple inflammatory profiles of microglia and altered neuroimages in APP/PS1 transgenic AD mice.
    Liu L; Liu Y; Li N; Huang R; Zheng X; Huang L; Hou S; Yuan Q
    Brain Res Bull; 2020 Mar; 156():86-104. PubMed ID: 31931120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial senescence alleviates cognitive impairment in a mouse model of Alzheimer's disease.
    Horibe S; Emoto T; Mizoguchi T; Tanaka T; Kawauchi S; Sasaki N; Yamashita T; Ikeda K; Emoto N; Hirata KI; Rikitake Y
    Glia; 2024 Jan; 72(1):51-68. PubMed ID: 37610154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early-life stress lastingly alters the neuroinflammatory response to amyloid pathology in an Alzheimer's disease mouse model.
    Hoeijmakers L; Ruigrok SR; Amelianchik A; Ivan D; van Dam AM; Lucassen PJ; Korosi A
    Brain Behav Immun; 2017 Jul; 63():160-175. PubMed ID: 28027926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related changes in hippocampal AD pathology, actin remodeling proteins and spatial memory behavior of male APP/PS1 mice.
    Sun H; Liu M; Sun T; Chen Y; Lan Z; Lian B; Zhao C; Liu Z; Zhang J; Liu Y
    Behav Brain Res; 2019 Dec; 376():112182. PubMed ID: 31472195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease.
    Naert G; Rivest S
    J Neurosci; 2011 Apr; 31(16):6208-20. PubMed ID: 21508244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral inoculation of human A53T α-synuclein reduces spatial memory decline and amyloid-β aggregation in APP/PS1 transgenic mice of Alzheimer's disease.
    Hao YN; Lu QX; Zhai YH; Wang HY; Wu MN; Hu MM; Yang B; Wang ZJ; Wu ZW; Qi JS
    Brain Res Bull; 2018 Oct; 143():116-122. PubMed ID: 30366065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haploinsufficiency of microglial MyD88 ameliorates Alzheimer's pathology and vascular disorders in APP/PS1-transgenic mice.
    Quan W; Luo Q; Hao W; Tomic I; Furihata T; Schulz-Schäffer W; Menger MD; Fassbender K; Liu Y
    Glia; 2021 Aug; 69(8):1987-2005. PubMed ID: 33934399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent hypoxia training enhances Aβ endocytosis by plaque associated microglia via VPS35-dependent TREM2 recycling in murine Alzheimer's disease.
    Wang X; Xie Y; Fan X; Wu X; Wang D; Zhu L
    Alzheimers Res Ther; 2024 Jun; 16(1):121. PubMed ID: 38831312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.